Literature DB >> 30824244

Recent Developments in the Treatment of Depression.

Steven D Hollon1, Zachary D Cohen2, Daisy R Singla3, Paul W Andrews4.   

Abstract

The cognitive and behavioral interventions can be as efficacious as antidepressant medications and more enduring, but some patients will be more likely to respond to one than the other. Recent work has focused on developing sophisticated selection algorithms using machine-learning approaches that answer the question, "What works best for whom?" Moreover, the vast majority of people suffering from depression reside in low- and middle-income countries where access to either psychotherapy or medications is virtually nonexistent. Great strides have been made in training nonspecialist providers (known as task sharing) to overcome this gap. Finally, recent work growing out of evolutionary psychology suggests that antidepressant medications may suppress symptoms at the expense of prolonging the underlying episode so as to increase the risk of relapse whenever someone tries to stop. We address each of these developments and their cumulative implications.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  antidepressant medications; cognitive behavior therapy; iatrogenic effect; treatment selection algorithms, global mental health

Mesh:

Substances:

Year:  2019        PMID: 30824244     DOI: 10.1016/j.beth.2019.01.002

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  5 in total

1.  Combined Cognitive-Behavioral Therapy and Placebo Treatment for Patients with Depression: A Follow-Up Assessment.

Authors:  Anne Schienle; Nina Jurinec
Journal:  Psychol Res Behav Manag       Date:  2021-02-22

Review 2.  Antidepressant Potential of Cinnamic Acids: Mechanisms of Action and Perspectives in Drug Development.

Authors:  Lúcio Ricardo Leite Diniz; Marilia Trindade de Santana Souza; Joice Nascimento Barboza; Reinaldo Nóbrega de Almeida; Damião Pergentino de Sousa
Journal:  Molecules       Date:  2019-12-06       Impact factor: 4.411

Review 3.  Efficacy of bio- and neurofeedback for depression: a meta-analysis.

Authors:  J Fernández-Alvarez; M Grassi; D Colombo; C Botella; P Cipresso; G Perna; G Riva
Journal:  Psychol Med       Date:  2021-11-15       Impact factor: 7.723

4.  Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.

Authors:  Ángel Aguilera-Martín; Mario Gálvez-Lara; Fátima Cuadrado; Eliana Moreno; Francisco García-Torres; José F Venceslá; Jorge Corpas; Francisco J Jurado-González; Roger Muñoz-Navarro; César González-Blanch; Paloma Ruiz-Rodríguez; Sara Barrio-Martínez; Maider Prieto-Vila; María Carpallo-González; Antonio Cano-Vindel; Juan A Moriana
Journal:  BMC Psychiatry       Date:  2022-02-09       Impact factor: 3.630

5.  Design and Preliminary Realization of a Screening and Early Warning Health Management System for Populations at High Risk for Depression.

Authors:  Xin Chen; Liangwen Xu; Zhigeng Pan
Journal:  Int J Environ Res Public Health       Date:  2022-03-18       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.